Skip to main content
SpringerLink
Log in

Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas

  • Short Communication
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

We previously reported (UroOncology 1:165, 2001) cross-resistance and collateral-sensitivity to 2-chlorodeoxyadenosine (CldAdo) and fludarabine (FaraA), respectively, in a human renal cell carcinoma selected for resistance to 2′-deoxytubercidin (Caki-dTub). Insofar that these drugs generally demonstrate cross resistance rather than collateral sensitivity, we further examined the bases for this phenomenon. Both CldAdo and FaraA induce apoptosis, as the triphosphates, via binding to Apaf-1. In the presence of cytochrome c, this binding leads to activation of procaspase 9 to active caspase 9 that induces apoptosis through its activation of caspase 3. CldAdo and FaraA induced caspase 3 activities in wild type and Caki-dTub cell lines in a dose-dependent manner that paralleled the cross-resistance (CldAdo, 200-fold) or collateral sensitivity (FaraA, 20-fold) with regard to cell viability. The activation of caspase 3 was inhibited by the caspase 9 inhibitor, Z-LEHD-FMK, suggesting that both drugs act via the same pathway. By differential display and direct enzyme analysis, dihydrodiol dehydrogenase (DDH) was observed to be profoundly underexpressed in the Caki-dTub compared to wild-type Caki-1 cells. Stable transfection of the Caki-dTub cells with a vector encoding the enzyme led to partial reversal of the resistance to CldAdo. Resistance to cisplatin has recently been ascribed to overexpression of DDH in a human ovarian carcinoma cell line (Deng et al. in J Biol Chem 227:15035, 2002). It is tempting to speculate a mutation in the Apaf-1 nucleotide binding site that reduces (CldAdo) or increases (FaraA) toxicity in the Caki-dTub cells; however, the recent finding by others in a human ovarian carcinoma cell line suggests that DDH expression mediates the cross-resistance and perhaps, collateral-sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Deng HB, Parekh HK, Chow K-C, Simpkins H (2002) Increased expression of dihydrodiol dehydrogenase in human ovarian carcinoma cells. J Biol Chem 277:15035–15043

    Article  PubMed  CAS  Google Scholar 

  2. Penning TM (1993) Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism. Chem Biol Interact 89:1–34

    Article  PubMed  CAS  Google Scholar 

  3. Parekh H, Simpkins H (1996) Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. Cancer Chemoth Pharmacol 37:457–462

    Article  CAS  Google Scholar 

  4. Deng HB, Adikari M, Parekh H, Simpkins H (2004) Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase. Cancer Chemoth Pharmacol 54:301–307

    CAS  Google Scholar 

  5. Pan BF, Nelson JA (2001) Multidrug resistance and collateral sensitivity in a human renal carcinoma selected for resistance to 2′-deoxytubercidin. UroOncology 1:165–174

    CAS  Google Scholar 

  6. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203–210

    Article  PubMed  CAS  Google Scholar 

  7. Thornberry NA (1994) Interleukin-1β converting enzyme. Meth Enzymol 244:615–631

    Article  PubMed  CAS  Google Scholar 

  8. Linskens MH, Feng J, Andrews WH, Enlow BE, Saati SM, Tonkin LA, Funk WD, Villeponteau B (1995) Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res 23:3244–3251

    Article  PubMed  CAS  Google Scholar 

  9. Stolz A, Hammond L, Lou H, Takikawa H, Ronk M, Shively JE (1993) cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. J Biol Chem 268(14):10448–10457

    PubMed  CAS  Google Scholar 

  10. Ciaccio PJ, Jaiswal AK, Tew KD (1994) Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics. J Biol Chem 269:15558–15562

    PubMed  CAS  Google Scholar 

  11. Ciaccio PJ, Stuart JE, Tew KD (1993) Overproduction of a 37.5-kDa cytosolic protein structurally related to prostaglandin F synthase in ethacrynic acid-resistant human colon cells. Mol Pharmacol 43:845–853

    PubMed  CAS  Google Scholar 

  12. Ciaccio PJ, Walsh ES, Tew KD (1996) Promoter analysis of a human dihydrodiol dehydrogenase. Biochem Biophys Res Comm 228:524–529

    Article  PubMed  CAS  Google Scholar 

  13. Hsu N-Y, Ho H-C, Chow K-C, Lin T-Y, Shih C-S, Wang L-S, Tsai C-M (2001) Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 61:2727–2731

    PubMed  CAS  Google Scholar 

  14. Peethambaram PP, Long HJ (2002) Second-line and subsequent therapy for ovarian carcinoma. Curr Oncol Rep 4:159–164

    PubMed  Google Scholar 

  15. Konno R (2001) Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray. Human Cell 14:261–266

    PubMed  CAS  Google Scholar 

  16. Robak T, Kasznicki M (2002) Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Leukemia 16:1015–1027

    Article  PubMed  CAS  Google Scholar 

  17. Leoni LM, Chao Q, Cottam HB, Genini D, Rosenbach M, Carrera CJ, Budihardjo I, Wang X, Carson DA (1998) Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c. Proc Natl Acad Sci USA 95:9567–9571

    Article  PubMed  CAS  Google Scholar 

  18. Genini D, Budihardjo I, Plunkett W, Wang X, Carrera CJ, Cottam HB, Carson DA, Leoni LM (2000) Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway. J Biol Chem 275:29–34

    Article  PubMed  CAS  Google Scholar 

  19. Penning TM, Ohnishi ST, Ohnishi T, Harvey RG (1996) Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem Res Toxicol 9:84–92

    Article  PubMed  CAS  Google Scholar 

  20. Tsuruda L, Hou YT, Penning TM (2001) Stable expression of rat dihydrodiol dehydrogenase (AKR1C9) in human breast MCF-7 cells results in the formation of PAH-o-quinones and enzyme mediated cell death. Chem Res Toxicol 14:856–862

    Article  PubMed  CAS  Google Scholar 

  21. Hamaoka R, Fujii J, Miyagawa J-I, Takahashi M, Kishimoto M, Moriwaki M, Ymamato K, Kajimoto Y, Yamasaki Y, Hanagus T, Matsuzawa Y, Taniguchi N (1999) Overexpression of the aldose reductase gene induces apoptosis in pancreatic ß-cells by causing a redox imbalance. J Biochem 126:41–47

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Pathology, Unit 951, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, P.O. Box 301429, Houston, TX, 77230-1429, USA

    Bih Fang Pan

  2. Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77230-1429, USA

    J. Arly Nelson

Authors
  1. Bih Fang Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Arly Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bih Fang Pan.

Additional information

This work was supported by a National Institutes of Health Grant, DK-41606, from the Institute for Diabetes, Digestive Diseases and Kidney, U.S. Public Health Service.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pan, B.F., Nelson, J.A. Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas. Cancer Chemother Pharmacol 59, 697–702 (2007). https://doi.org/10.1007/s00280-006-0351-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-006-0351-1

Keywords

Search

Navigation